|
|
|
|
Roche expands Herceptin franchise
Roches blockbuster breast cancer treatment Herceptin has been launched in the UK as a treatment for stomach cancer.It is a boost for the Herceptin franchise - already worth $4.8 billion to the manufacturer - demonstrating that targeting HER2...
|
|
|
UK green light for Herceptin in gastric cancer
Patients with gastric cancer in the UK have been given access to a new treatment option following the extended approval of Swiss drugmaker Roches biologic Herceptin.Specifically, regulators have issued a green light for Herceptin (trastuzumab) to treat...
|
|
|
Musical inspired by woman's cancer story
A MUSICAL inspired by one woman's cancer story is being premiered in Sussex this month.The countdown is on to the opening night of The Dream Maker written by mum-of-three Jill Landskroner. Jill, of Sedgwick Lane, Horsham, has penned 26 songs for the show...
|
|
|
GSK Tykerb Poised To Make Inroads Against Roche's Herceptin After Adding First-Line Indication
_ GSK Tykerb Poised To Make Inroads Against Roche's Herceptin After Adding First-Line Indication.
|
|
|
Musical inspired by woman's cancer story A MUSICAL inspired by one woman's cancer story is being premiered in
A MUSICAL inspired by one woman's cancer story is being premiered in Sussex this month.The countdown is on to the opening night of The Dream Maker written by mum-of-three Jill Landskroner. Jill, of Sedgwick Lane, Horsham, has penned 26 songs for the show...
|
|
|
Musical inspired by woman's cancer story
A MUSICAL inspired by one woman's cancer story is being premiered in Sussex this month.The countdown is on to the opening night of The Dream Maker written by mum-of-three Jill Landskroner.Jill, of Sedgwick Lane, Horsham, has penned 26 songs for the show...
|
|
|
Musical inspired by woman's cancer story
A MUSICAL inspired by one woman's cancer story is being premiered in Sussex this month.The countdown is on to the opening night of The Dream Maker written by mum-of-three Jill Landskroner. Jill, of Sedgwick Lane, Horsham, has penned 26 songs for the show...
|
|
|
Musical inspired by woman's cancer story
A MUSICAL inspired by one woman's cancer story is being premiered in Sussex this month.The countdown is on to the opening night of The Dream Maker written by mum-of-three Jill Landskroner.Jill, of Sedgwick Lane, Horsham, has penned 26 songs for the show...
|
|
|
Musical inspired by woman's cancer story
A MUSICAL inspired by one woman's cancer story is being premiered in Sussex this month.The countdown is on to the opening night of The Dream Maker written by mum-of-three Jill Landskroner.Jill, of Sedgwick Lane, Horsham, has penned 26 songs for the show...
|
|
|
Musical inspired by woman's cancer story
A MUSICAL inspired by one woman's cancer story is being premiered in Sussex this month.The countdown is on to the opening night of The Dream Maker written by mum-of-three Jill Landskroner.Jill, of Sedgwick Lane, Horsham, has penned 26 songs for the show...
|
|
|
Musical inspired by woman's cancer story
A MUSICAL inspired by one woman's cancer story is being premiered in Sussex this month.The countdown is on to the opening night of The Dream Maker written by mum-of-three Jill Landskroner.Jill, of Sedgwick Lane, Horsham, has penned 26 songs for the show...
|
|
|
Musical inspired by woman's cancer story
A MUSICAL inspired by one woman's cancer story is being premiered in Sussex this month.The countdown is on to the opening night of The Dream Maker written by mum-of-three Jill Landskroner.Jill, of Sedgwick Lane, Horsham, has penned 26 songs for the show...
|
|
|
Musical inspired by woman's cancer story
A MUSICAL inspired by one woman's cancer story is being premiered in Sussex this month.The countdown is on to the opening night of The Dream Maker written by mum-of-three Jill Landskroner.Jill, of Sedgwick Lane, Horsham, has penned 26 songs for the show...
|
|
|
Strong operating performance for Roche in 2009
The total Roche Group's sales grew by 10% in local currencies (8% in Swiss francs; 7% in US dollars) to 49.1 billion Swiss francs, with the Pharmaceuticals Division accounting for 80% of Group sales and the Diagnostics Division contributing 20%.Sales growth...
|
|
|
Viv wins 13,000 cancer drug refund
A HEALTH trust has refunded 13,000 to a cancer sufferer forced to pay for Herceptin privately, after telling her she can now have the drug on the NHS.Viv Foster, pictured above, had lost two appeals in her seven-month battle for Herceptin on the...
|
|
|
FDA Okays Drug Combo for Advanced Breast Cancer
The U.S.Food and Drug Administration (FDA) has approved the combination of the targeted therapy Tykerb (chemical name: lapatinib) and the hormonal therapy Femara (chemical name: letrozole) to treat post-menopausal women diagnosed with hormone-receptor...
|
|
|
Datamonitor: Roche - novel Herceptin formulation promises greater convenience on reports-research.com
This strategy could help to conserve its share of an increasingly competitive market, but may be challenging to implement due to concerns over compliance and financial incentives to prescribe intravenous cancer drugs.Roche has invested roughly CHF190m ($183m...
|
|
|
Breast Cancer Treatment Trastuzumab Increases Survival By Third
A recent breakthrough by Finnish researches has led to a new.The treatment targets the common HER2 type of breast cancer and cuts deaths by as much as a third. The new treatment is called trastuzumab. Breast cancer affects as many as 1 in 8 women a year....
|
|
|
Genentech deal, Tamiflu sales lift Roche
DERMOT DOHERTY ROCHE Holding reported an 11% increase in second-half profit yesterday, helped by cost savings from its takeover of Genentech and higher demand for swine flu drug Tamiflu.Profit excluding some costs advanced to Sf4,59bn (4,35bn) from Sf4,15bn...
|
|
|
Roche Avastin Sales Effort Lost Steam in Quarter (Update1)
Roche Avastin Sales Effort Lost Steam in Quarter (Update1) (Adds closing share price in 10th paragraph.) Feb.3 (Bloomberg) -- Roche Holding AG overhauled the sales efforts for its best-selling drug, the Avastin cancer treatment, after the company lost steam...
|
|
|
Roche Avastin Sales Effort Lost Steam in Quarter, Soriot Says
3 (Bloomberg) -- Roche Holding AG overhauled the sales efforts for its best-selling drug, the Avastin cancer treatment, after the company lost steam during the fourth quarter.Sales of the medicine were hurt by a focus on selling it as a treatment for breast...
|
|
|
MEDCAC Review of PGx Cancer Tests Finds Some Clinical Utility, More Evidentiary Gaps
Pharmacogenomic tests to guide treatment with Herceptin for breast cancer, Gleevec in chronic myelogenous leukemia, and Vectibix and Erbitux for colorectal cancer improve patient outcomes, an advisory panel for the Centers for Medicare and Medicaid...
|
|
|
Roche 2009 profit down 22 pct on Genentech costs
Discounting one-off expenses, net profit attributable to Roche shareholders would have fallen 9 percent to 9.8 billion francs, it said.The results fell just short of analyst expectations. Shares in Roche, which reports earnings figures only for the half...
|
|
|
Strong operating performance for Roche in 2009
BASEL, Switzerland, Feb.3, 2010--Record sales, double-digit growth in operating profit and Core Earnings per share Dividend increase by 20% to 6.00 Swiss francs proposed 1 LC= local currencies 2 Proposed by the Board of Directors. 3 before exceptional...
|
|
|
Advisory Panel Rates Genomic Cancer Tests
Some genomic tests aimed at identifying patients most likely to respond to cancer drugs won a thumbs-up from a advisory panel, but others didn't make the grade.As part of a national coverage determination under way at the Centers for and Services, members of...
|
